Mitochondrial protein BNIP3 regulates Chikungunya virus replication in the early stages of infection

PLoS Negl Trop Dis. 2023 Nov 27;17(11):e0010751. doi: 10.1371/journal.pntd.0010751. eCollection 2023 Nov.

Abstract

Chikungunya virus (CHIKV) is a human pathogen causing outbreaks of febrile illness for which vaccines and specific treatments remain unavailable. Autophagy-related (ATG) proteins and autophagy receptors are a set of host factors that participate in autophagy, but have also shown to function in other unrelated cellular pathways. Although autophagy is reported to both inhibit and enhance CHIKV replication, the specific role of individual ATG proteins remains largely unknown. Here, a siRNA screen was performed to evaluate the importance of the ATG proteome and autophagy receptors in controlling CHIKV infection. We observed that 7 out of 50 ATG proteins impact the replication of CHIKV. Among those, depletion of the mitochondrial protein and autophagy receptor BCL2 Interacting Protein 3 (BNIP3) increased CHIKV infection. Interestingly, BNIP3 controls CHIKV independently of autophagy and cell death. Detailed analysis of the CHIKV viral cycle revealed that BNIP3 interferes with the early stages of infection. Moreover, the antiviral role of BNIP3 was found conserved across two distinct CHIKV genotypes and the closely related Semliki Forest virus. Altogether, this study describes a novel and previously unknown function of the mitochondrial protein BNIP3 in the control of the early stages of the alphavirus viral cycle.

MeSH terms

  • Chikungunya Fever*
  • Chikungunya virus* / physiology
  • Humans
  • Membrane Proteins / genetics
  • Membrane Proteins / metabolism
  • Mitochondrial Proteins / genetics
  • Mitochondrial Proteins / metabolism
  • Proto-Oncogene Proteins / metabolism
  • Proto-Oncogene Proteins c-bcl-2 / metabolism
  • Virus Replication / physiology

Substances

  • Mitochondrial Proteins
  • Proto-Oncogene Proteins c-bcl-2
  • BNIP3 protein, human
  • Membrane Proteins
  • Proto-Oncogene Proteins

Grants and funding

F.R. is supported by ZonMW TOP (91217002), Open Competition ENW-KLEIN (OCENW.KLEIN.118) and Marie Skłodowska Curie ETN (765912) grants. J.S., F.R. and N.D.K. were supported by a Skłodowska-Curie Cofund (713660). L.E. was supported by Erasmus Mundus EURICA mobility programme and Graduate School of Medical Sciences PhD scholarship (University Medical Center Groningen). M.M. and D.v.d. Pol were supported by the University Medical Center Groningen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.